Table 2.
Organ-Specific Lesion-Based Analysis of Suspicious FDG-PET/CT Uptake
Site of Disease | Sites |
Sensitivity |
Specificity |
|||
---|---|---|---|---|---|---|
No. | % | % | 95% CI (%) | % | 95% CI (%) | |
Lymph node | 51 | 38 | 92 | 74 to 99 | 81 | 61 to 93 |
Lung | 31 | 23 | 88 | 62 to 98 | 87 | 60 to 98 |
Bone | 22 | 17 | 93 | 66 to 100 | 100 | 63 to 100 |
Liver | 10 | 7 | 50 | 12 to 88 | 100 | 40 to 100 |
Soft tissue | 11 | 8 | 100 | 40 to 100 | 86 | 42 to 100 |
Adrenal | 6 | 4 | 100 | 25 to 100 | 100 | 48 to 100 |
Kidney | 4 | 3 | 100 | 3 to 100 | 100 | 29 to 100 |
Total sites | 135 | 100 | 87 | 76 to 94 | 88 | 78 to 95 |
Abbreviations: FDG, fluorine-18 2-fluoro-2-deoxy-D-glucose; PET, positron emission tomography; CT, computed tomography.